• Facebook
  • Twitter
  • LinkedIn
  • Google +
  • RSS

PsiOxus Therapeutics - Articles and news items

BMS and PsiOxus to evaluate Opdivo and enadenotucirev in cancer

Industry news / 1 July 2016 / Victoria White, Digital Content Producer

The companies are to evaluate the safety, tolerability and efficacy of enadenotucirev and Opdivo in a range of tumour types in late-stage cancer patients…

PsiOxus initiates study of Keytruda and enadenotucirev in carcinomas

Industry news / 22 December 2015 / Victoria White

Enadenotucirev is an oncolytic virus that has been shown in Phase I clinical trials to reach and selectively infect cancer cells when administered by intravenous infusion…